scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM031036F |
P698 | PubMed publication ID | 14998325 |
P50 | author | Antonello Mai | Q40107985 |
Rino Ragno | Q42622812 | ||
Sergio Valente | Q56806688 | ||
Patrizia Bottoni | Q57628658 | ||
Ilaria Cerbara | Q117821586 | ||
Peter Loidl | Q120598748 | ||
P2093 | author name string | Silvio Massa | |
Roberto Scatena | |||
Florian Jesacher | |||
Gerald Brosch | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1351-1359 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies | |
P478 | volume | 47 |
Q36868771 | An E/Z conformational behaviour study on the trypanocidal action of lipophilic spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acids |
Q40246576 | Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition |
Q37397325 | Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors |
Q30489011 | Docking Screens for Novel Ligands Conferring New Biology |
Q38195005 | Epigenetic molecular recognition: a biomolecular modeling perspective |
Q37693855 | Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives |
Q37125200 | Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market |
Q42067105 | Hydroxamic acid - A novel molecule for anticancer therapy. |
Q38089836 | Indolyl aryl sulphones as HIV-1 reverse transcriptase inhibitors: docking and 3D QSAR studies |
Q40281693 | Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? |
Q39176128 | tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells |
Search more.